Pacira BioSciences | Sustainability Performance
Develops and commercializes non-opioid pain management and regenerative health solutions, focusing on improving patient outcomes in various medical procedures.
2006
United States
501 - 1,000 employees
Pharmaceuticals
$500M - 1B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4891
Overallⓘ#1024
in United Statesⓘ#105
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Pacira's Exparel non-opioid pain product faced clinical debate about efficacy.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.